2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Epilim should preferably be taken with or after food: the enteric-coated tablet (lilac) must be swallowed whole, if necessary with a little water: the …
Download 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
Presentation, Advantan presentation uses, Advantan, Uses, Methylprednisolone aceponate, Methylprednisolone, Aceponate
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Draft, Good, Practices, Manufacturing, Edition, Edition draft, Good manufacturing practice
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Crushing tablets – issues to consider - Auspharm
www.auspharmacist.net.auCrushing tablets – issues to consider Au sPharmacist.net.au CE 21/10/2010 Valproate (Epilim) 1 Epilim crushable tablets Antiglycaemic agents
Issue, Tablets, Consider, Crushing tablets issues to consider, Crushing, Epilim
MEDICINES CONTROL COUNCIL - mccza.com
www.mccza.comAdministration Notification of Registration of Medicines 12.52 Notification of Registration Apr10v1.doc May 2010 Page 1 of 4 MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE
Sizwe Medical Fund: CDL Formulary - All Options
www.sizwe.co.zaSizwe Medical Fund: CDL Formulary - All Options This formulary is a summary of treatment covered on the Chronic Disease List (CDL) Formulary.
Medical, Fund, Options, Formulary, Sizwe, Sizwe medical fund, Cdl formulary all options
SCHEDULING STATUS: S3 PROPRIETARY NAME …
www.epilepsy.org.za1 SCHEDULING STATUS: S3 PROPRIETARY NAME (and dosage form): Epilim® Liquid Sugar-free (Liquid) Epilim® CR 200 (Prolonged Release Tablets) Epilim® CR 300 (Prolonged Release Tablets)
Name, Scheduling, Tablets, Status, Proprietary, Scheduling status, S3 proprietary name, Epilim
SUMMARY OF PRODUCT CHARACTERISTICS - Sanofi
www.sanofi-aventis.co.ukSUMMARY OF PRODUCT CHARACTERISTICS 1. Name of the medicinal product Epilim 100mg Crushable Tablets Epilim 200 Enteric Coated Tablets Epilim 500 Enteric Coated Tablets
Product, Summary, Tablets, Characteristics, Summary of product characteristics, Epilim, Tablets epilim
GUIDELINES FOR THE MONITORING OF …
www.neneccg.nhs.ukGUIDELINES FOR THE MONITORING OF ANTIMANIC AND PROPHYLACTIC MEDICATION IN BIPOLAR DISORDER NHT Policy number MM-G-023 Date approved by Medicines Management
Epilim - Medsafe Home Page
www.medsafe.govt.nzEpilim Oral NZ Page 3 The lilac tablets have a special coating to stop them dissolving until they have gone through the stomach and into the intestines.
SUMMARY OF PRODUCT CHARACTERISTICS - Sanofi
www.sanofi-aventis.co.ukSUMMARY OF PRODUCT CHARACTERISTICS 1 Name of the medicinal product Depakote 250mg Tablets. Depakote 500mg Tablets. 2 …
Product, Summary, Tablets, Characteristics, Summary of product characteristics
SODIUM VALPROATE IN CHILDHOOD EPILEPSY - …
archives.who.intSodium valproate page 1 SODIUM VALPROATE IN CHILDHOOD EPILEPSY Report prepared for the World Health Organisation November 2006 1. Summary statement of the proposal for inclusion, change or
Sodium, Childhood, Epilepsy, Valproate, Sodium valproate in childhood epilepsy
Related search queries
Crushing tablets – issues to consider, Epilim, Tablets, MEDICINES CONTROL COUNCIL, Sizwe Medical Fund: CDL Formulary - All Options, SCHEDULING STATUS: S3 PROPRIETARY NAME, Tablets) Epilim, SUMMARY OF PRODUCT CHARACTERISTICS, Tablets Epilim, GUIDELINES FOR THE MONITORING OF, SODIUM VALPROATE IN CHILDHOOD EPILEPSY